GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 77 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | – | 324 | +1017.2% | 0.00% | – |
Q1 2023 | $0 | – | 29 | -90.2% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 296 | -88.2% | 0.00% | – |
Q3 2021 | $10,000 | -44.4% | 2,500 | -53.7% | 0.00% | – |
Q2 2021 | $18,000 | +157.1% | 5,397 | +60.4% | 0.00% | – |
Q1 2021 | $7,000 | -12.5% | 3,364 | -6.0% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 3,580 | +320.2% | 0.00% | – |
Q3 2020 | $2,000 | -50.0% | 852 | -28.2% | 0.00% | – |
Q2 2020 | $4,000 | -83.3% | 1,186 | -90.1% | 0.00% | – |
Q1 2020 | $24,000 | +700.0% | 12,012 | +865.6% | 0.00% | – |
Q4 2019 | $3,000 | -40.0% | 1,244 | -11.8% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 1,410 | +28.2% | 0.00% | – |
Q2 2019 | $5,000 | -16.7% | 1,100 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +50.0% | 1,100 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -77.8% | 1,100 | -62.4% | 0.00% | – |
Q3 2018 | $18,000 | +80.0% | 2,925 | +82.8% | 0.00% | – |
Q2 2018 | $10,000 | +233.3% | 1,600 | +166.7% | 0.00% | – |
Q1 2018 | $3,000 | +50.0% | 600 | -13.3% | 0.00% | – |
Q4 2017 | $2,000 | – | 692 | +2561.5% | 0.00% | – |
Q3 2017 | $0 | – | 26 | +766.7% | 0.00% | – |
Q2 2017 | $0 | – | 3 | -98.2% | 0.00% | – |
Q4 2016 | $0 | – | 167 | +247.9% | 0.00% | – |
Q2 2016 | $0 | – | 48 | -81.2% | 0.00% | – |
Q4 2015 | $0 | – | 255 | -39.6% | 0.00% | – |
Q3 2015 | $0 | – | 422 | +58.1% | 0.00% | – |
Q2 2015 | $0 | – | 267 | +167.0% | 0.00% | – |
Q1 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
Q1 2014 | $2,000 | +100.0% | 100 | -10.7% | 0.00% | – |
Q4 2013 | $1,000 | 0.0% | 112 | +12.0% | 0.00% | – |
Q3 2013 | $1,000 | 0.0% | 100 | -60.0% | 0.00% | – |
Q2 2013 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
Virtu Financial LLC | 14,683 | $32,000 | 0.00% |